Psychemedics (PMD) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
Proposal 7 concerns the potential adjournment of the annual meeting, allowing flexibility if more time is needed for voting or discussion.
The NYSE has classified the Adjournment Proposal as a routine matter, enabling brokers to vote at their discretion if shareholders do not provide instructions.
No broker non-votes are expected for the Adjournment Proposal due to its routine status.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Psychemedics
- Approval sought for stock split, buyout, and delisting to go private and reduce costs.PMD
Proxy Filing2 Dec 2025 - Approval sought for going-private transaction, cashing out small holders and delisting shares.PMDProxy Filing2 Dec 2025
- Proposals seek approval for delisting, deregistration, and cashing out small shareholders at $2.35 per share.PMDProxy Filing2 Dec 2025
- Stockholders to vote on going-private plan, cashing out small holders and delisting from Nasdaq.PMDProxy Filing2 Dec 2025
- Reverse split, delisting, and private placement to cut costs and cash out small holders, pending vote.PMDProxy Filing2 Dec 2025
- Q3 2024 revenue fell 9% as net loss narrowed and delisting plans advanced.PMDQ3 202413 Jun 2025
- Q2 2024 revenue fell 15% and net loss widened as delisting aims to cut costs.PMDQ2 202413 Jun 2025
- 2024 revenue declined 11% and company delisted from Nasdaq, but net loss improved.PMDQ4 20249 Jun 2025